A. V. D. Meer

发表

Faculty Opinions recommendation of Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized Trial.

A. V. D. Meer, 2016 .

Achieving sustained virological response: what’s the impact on further hepatitis C virus-related disease?

A. V. D. Meer, A. J. Meer, 2015 .

Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection

A. V. D. Meer, 2015 .

Antiviral Therapy for Chronic HCV Infection: Virological Response and Long-Term Outcome

A. V. D. Meer, A. J. Meer, 2014 .

Faculty Opinions recommendation of Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study.

A. V. D. Meer, A. J. Meer, 2016 .

Value anti-hepatitis C virus therapy by its clinical efficacy.

A. V. D. Meer, 2015 .

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

Gamal Esmat, Rui Tato Marinho, Mel Krajden, 2017, The lancet. Gastroenterology & hepatology.

Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.

M. Manns, V. de Lédinghen, M. Buti, 2017, The lancet. Gastroenterology & hepatology.

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.

S. Alavian, R. Malekzadeh, V. Wong, 2018, The lancet. Gastroenterology & hepatology.

Natural History of HCV-induced Liver Disease

R. D. Knegt, B. Veldt, R. Maan, 2013, Current Hepatitis Reports.

CHAPTER 2 MIRAVIRSEN DOSING IN CHRONIC HEPATITIS C PATIENTS RESULTS IN DECREASED MICRORNA-122 LEVEL WITHOUT AFFECTING OTHER MICRORNA ’ S IN PLASMA

N. Kootstra, H. Janssen, H. Reesink, 2017 .

Search for a natural killer: a case report

A. V. D. Meer, L. Louter, R. Schop, 2016, International Journal of Colorectal Disease.